Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Danaher    DHR

DANAHER (DHR)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/12/2018 02/13/2018 02/14/2018 02/15/2018 02/16/2018 Date
95.41(c) 94.98(c) 96.1(c) 97.47(c) 97.54(c) Last
2 247 606 2 012 625 1 504 893 1 896 594 1 855 195 Volume
+1.01% -0.45% +1.18% +1.43% +0.07% Change
More quotes
Financials ($)
Sales 2018 19 423 M
EBIT 2018 3 760 M
Net income 2018 2 665 M
Debt 2018 6 494 M
Yield 2018 0,60%
Sales 2019 20 311 M
EBIT 2019 4 074 M
Net income 2019 3 010 M
Debt 2019 3 260 M
Yield 2019 0,64%
P/E ratio 2018 25,77
P/E ratio 2019 23,41
EV / Sales2018 3,83x
EV / Sales2019 3,50x
Capitalization 67 849 M
More Financials
Company
Danaher Corp. operates as a medical company, which designs, manufactures, and markets healthcare, environmental, and industrial equipment.It operates through the following segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.The Life Sciences segment offers a range of... 
Sector
Advanced Medical Equipment & Technology
Calendar
02/21 | 04:20pmPresentation
More about the company
Surperformance© ratings of Danaher
Trading Rating : Investor Rating :
More Ratings
Latest news on DANAHER
12:22pGLYCOBIOLOGY MARKET 2017 TO 2025 BY : Agilent Technologies Inc, Waters Corporat..
AQ
02/14DANAHER : To Present At Barclays Industrial Select Conference
PR
02/08DANAHER : Announces Transition Plan For Chief Financial Officer
AQ
02/08DANAHER : Free Research Report as Danaher’s Quarterly Revenue Jumped 11.0%; Adju..
AC
02/01DANAHER : Announces transition plan for chief financial officer
AQ
02/01DANAHER : Reports fourth quarter and full year 2017 results
AQ
01/30DANAHER : Beats Estimates as Diagnostics Sales Increase -- Earnings Review
DJ
01/30DANAHER : tops Street 4Q forecasts
AQ
01/30DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
AQ
01/30DANAHER CORP /DE/ : Change in Directors or Principal Officers, Financial Stateme..
AQ
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09:08aSiemens plans Healthineers IPO in first half of 2018
RE
02/08ATHENAHEALTH : Former GE CEO Jeff Immelt Named Chairman of Athenahealth -- Updat..
DJ
02/07GENERAL ELECTRIC : Former GE CEO Jeff Immelt Named Chairman of Athenahealth
DJ
02/03ROYAL PHILIPS : Investors Seek Answers on Health Fund -- WSJ
DJ
02/02ROYAL PHILIPS : Abraaj Investors Hire Auditor to Trace Money
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on DANAHER 
DANAHER CORPORATION - 2012
Strong support to help a rebound
BUY
More Strategies
Latest Tweets
02/18Danaher $DHR Earning Somewhat Favorable Media Coverage, Analysis Finds  
02/17Danaher $DHR Receives New Coverage from Analysts at Barclays  
02/16$DHR - Danaher Co. #DHR Shares Bought by State of Wisconsin Investment Board .. 
02/16Rhumbline Advisers Acquires 15,542 Shares of Danaher Co. $DHR  
02/15Wealthstreet Investment Advisors LLC Invests $639,000 in Danaher Co. $DHR  
More tweets
Qtime:155
News from SeekingAlpha
02/02Roche Drifting Ahead Of Key Data 
02/01Dover's Ability To Create Long-Term Value Still An Open Question 
01/31Danaher Back On Track To Start 2018 
01/30Danaher Corporation's (DHR) CEO Tom Joyce on Q4 2017 Results - Earnings Call .. 
01/30Danaher Corporation 2017 Q4 - Results - Earnings Call Slides 
Chart DANAHER
Duration : Period :
Danaher Technical Analysis Chart | DHR | US2358511028 | 4-Traders
Technical analysis trends DANAHER
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 109 $
Spread / Average Target 12%
EPS Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Stephen M. Rales Chairman
Daniel L. Comas Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER3.53%66 848
THERMO FISHER SCIENTIFIC9.71%83 531
INTUITIVE SURGICAL12.32%45 927
BOSTON SCIENTIFIC CORPORATION8.15%37 200
ROYAL PHILIPS-1.49%36 661
ILLUMINA2.11%32 574